SGLT2 Inhibitors: SGLT2 Inhibitors are awaiting FDA approval as a new class of drugs; they block glucose re-absorption from renal filtrate.

SGLT2 Inhibitors a Promising New Therapy for Type II Diabetes: New Cutting Edge Information Report Analyzes Diabetes Market Forecast Through 2013
SGLT2 Inhibitors a Promising New Therapy for Type II Diabetes: New Cutting Edge Information Report Analyzes Diabetes Market Forecast Through 2013 Dec 12, 2008 MarketWatch RESEARCH TRIANGLE PA
SGLT2 Inhibitors a Promising New Therapy for Type II Diabetes: New Cutting Edge ...
SGLT2 Inhibitors for the Treatment of Diabetes
SGLT2 Inhibitors for the Treatment of Diabetes John P.H. Wilding, DM, FRCP Medscape Today Introduction The optimal treatment of hyperglycemia in type 2 diabetes remains a major clinical chall
http://www.medscape.com/viewarticle/578176
Sodium glucose co-transporter 2 (SGLT2) inhibitors as potential antidiabetic agents
Sodium glucose co-transporter 2 (SGLT2) inhibitors as potential antidiabetic agents Informa Pharmaceutical Science Expert Opinion on Therapeutic Patents November 2005, Vol. 15, No. 11, Pages 15
Sodium glucose co-transporter 2 (SGLT2) inhibitors as potential antidiabetic age...